<DOC>
	<DOCNO>NCT01904760</DOCNO>
	<brief_summary>Reconstruction use microvascular free tissue flap important management patient maxillofacial tumor . It often characterise long operation time , traumatic require restriction patient 's head movement postoperatively order prevent disruption microvascular anastomosis . Agitation delirium common patient free flap surgery , may lead serious consequence self extubation , injury even failure flap . Dexmedetomidine sedative co-analgesic drug high specificity Î±2-adrenoceptor . It widely use ICU sedation general hospital . However use free flap surgery well document . Furthermore effect Dexmedetomidine prevent delirium prove . The investigator hypothesize use Dexmedetomidine would reduce emergence agitation prevent delirium patient free flap surgery .</brief_summary>
	<brief_title>Dexmedetomidine Prevent Agitation After Free Flap Surgery</brief_title>
	<detailed_description />
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>patient undergo select maxillofacial surgery free flap reconstruction American Society Anesthesiologist ( ASA ) classification I II bradycardia ( &lt; 50 bpm ) severe heart block low blood pressure ( SBP &lt; 80mmHg ) Known allergy alpha 2 agonist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>agitation</keyword>
	<keyword>delirium</keyword>
	<keyword>dexmedetomidine</keyword>
	<keyword>head neck surgery</keyword>
	<keyword>microvascular free tissue transfer</keyword>
	<keyword>flap</keyword>
</DOC>